We found significantly more expression of endogenous Gas2 in CD34+ CML cells versus control cells (p<0.0001, n=3), but inhibition of either Shp2 or Gas2 almost completely reversed this Bcr-abl effect (Figure 6B). Here, GAS2 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.